DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Funds / MPM Bioventures 2014 (b), L.P.
MPM Bioventures 2014 (b), L.P.
Amounts, each with its basis
- Vintage
- 2014basis: name year
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- unknownwhat may be sold, not what was raised; file 021-21823702, sworn by the adviser or filed under this vehicle
- Form D sold
- unknown
- First sale
- unknown
- Reported GAV
- $9.7Mon the Form ADV filed Jun 26, 2024; the fund's assets, never its size or dry powder
- Owners (ADV)
- 13
- Reported on ADV
- Apr 1, 2015 to Jun 26, 2024
Fundraising evidence
Unknown
no Form D or close on record (fr-1)
A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Harvest
vintage over 7 years, still reported
age years: 12first sale: n/avintage year: $2,014adv gav as of: 2024-06-26vintage basis: name_yearform d sold usd: n/aform d offering usd: n/aform d latest filed at: n/a
The fund's own reporting through time
22 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Apr 1, 2015 | Venture Capital Fund | $1.2M | 12 | $100,000 | 1% | yes | |
| Nov 23, 2015 | Venture Capital Fund | $20.4M | 13 | $50,000 | 1% | yes | |
| Nov 24, 2015 | Venture Capital Fund | $20.4M | 13 | $50,000 | 1% | yes | |
| Nov 24, 2015 | Venture Capital Fund | $20.4M | 13 | $50,000 | 1% | yes | |
| Mar 29, 2016 | Venture Capital Fund | $20.8M | 13 | $50,000 | 1% | yes | |
| Feb 7, 2017 | Venture Capital Fund | $20.8M | 13 | $50,000 | 1% | yes | |
| Mar 30, 2017 | Venture Capital Fund | $20.6M | 12 | $50,000 | 1% | yes | |
| Mar 30, 2018 | Venture Capital Fund | $20.3M | 12 | $50,000 | 1% | yes | |
| Jul 6, 2018 | Venture Capital Fund | $20.3M | 12 | $50,000 | 1% | yes | |
| Mar 28, 2019 | Venture Capital Fund | $26.1M | 12 | $50,000 | 1% | yes | |
| Jul 16, 2019 | Venture Capital Fund | $26.1M | 12 | $50,000 | 1% | yes | |
| Mar 30, 2020 | Venture Capital Fund | $26.7M | 13 | $50,000 | 1% | yes | |
| Apr 21, 2020 | Venture Capital Fund | $26.7M | 13 | $50,000 | 1% | yes | |
| Mar 29, 2021 | Venture Capital Fund | $47.6M | 13 | $50,000 | 1% | yes | |
| Mar 23, 2022 | Venture Capital Fund | $28.5M | 13 | $50,000 | 1% | yes | |
| Nov 17, 2022 | Venture Capital Fund | $28.5M | 13 | $50,000 | 1% | yes | |
| Mar 30, 2023 | Venture Capital Fund | $14.2M | 13 | $50,000 | 1% | yes | |
| Oct 30, 2023 | Venture Capital Fund | $14.2M | 13 | $50,000 | 1% | yes | |
| Mar 28, 2024 | Venture Capital Fund | $9.7M | 13 | $50,000 | 1% | yes | |
| Jun 6, 2024 | Venture Capital Fund | $9.7M | 13 | $50,000 | 1% | yes | |
| Jun 6, 2024 | Venture Capital Fund | $9.7M | 13 | $50,000 | 1% | yes | |
| Jun 26, 2024 | Venture Capital Fund | $9.7M | 13 | $50,000 | 1% | yes |
Principals and agents
0 principals on Form D, 0 placement agents
No Form D related person on record.
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
1 events
- Apr 1, 2015MPM Bioventures 2014 (b), L.P. first reported on Form ADV by MPM Asset Management LLC (Venture Capital Fund), GAV $1,234,249Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Evidence
0 observations